Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Stromal cellsMuriel Vayssade, Marie-Danielle NagelCell Biology International|November 11, 2011
Akt and RhoA inhibition promotes anoikis of aggregated B16F10 melanoma cellsOumou Goundiam, Marie-Danielle Nagel, Muriel VayssadeCell Biology International|December 18, 2009
Growth and survival signalling in B16F10 melanoma cells in 3D cultureOumou Goundiam, Marie-Danielle Nagel, Muriel VayssadeBiochemical Pharmacology|May 15, 2002
Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatmentMuriel Vayssade, Laetitia Faridoni-Laurens, Jean Bénard, et al.Biomacromolecules|April 21, 2015
EGFR Inhibition by Curcumin in Cancer Cells: A Dual Mode of ActionMarcelina Starok, Pascal Preira, Muriel Vayssade, et al.Colloids and Surfaces. B, Biointerfaces|October 25, 2011
Preosteoblasts and fibroblasts respond differently to anatase titanium dioxide nanoparticles: a cytotoxicity and inflammation studyMarie-Charlotte Bernier, Karim El Kirat, Marie Besse, et al.Langmuir : the ACS Journal of Surfaces and Colloids|September 1, 2012
Titanium dioxide nanoparticles disturb the fibronectin-mediated adhesion and spreading of pre-osteoblastic cellsMarie-Charlotte Bernier, Marie Besse, Muriel Vayssade, et al.Plos One|October 14, 2016
Impact of TIEG1 Deletion on the Passive Mechanical Properties of Fast and Slow Twitch Skeletal Muscles in Female MiceMalek Kammoun, Philippe Pouletaut, Francis Canon, et al.International Journal of Cancer|April 26, 2005
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cellsMuriel Vayssade, Hedi Haddada, Laetitia Faridoni-Laurens, et al.Cancers|October 13, 2021
Fibroblasts Influence Metastatic Melanoma Cell Sensitivity to Combined BRAF and MEK InhibitionDelphine Morales, Pascale Vigneron, Ines Ferreira, et al.Pageof 3